
Today on Pharmaceutical Processing
Eli Lilly commits $4.5B to Indiana manufacturing sites, opens gene therapy plant
Eli Lilly (NYSE:LLY) announced today that it has committed an additional $4.5 billion investment across certain Indiana manufacturing sites. The company’s commitment extends to two of its three locations in Lebanon, Indiana. It brings its total Indiana capital expansion commitments since 2020 to more than $21 billion. This marks the latest investment across the U.S.,…Thermo Fisher unveils new cell therapy manufacturing platform
Thermo Fisher Scientific today announced the introduction of the Gibco CTS DynaXS single-use bioreactor for cell therapy manufacturing. Waltham, Massachusetts–based Thermo Fisher designed the expansion platform to help cell therapy developers scale manufacturing with control, flexibility and regulatory readiness. Thermo Fisher said its stirred-tank, single-use system supports cell expansion across development and early clinical volumes.…Sponsored Content See More >
Regulatory See More >

Putting patients first in clinical trials
Clinical trials offer clinicians a unique opportunity to lead advances in medicine, granting access to cutting-edge therapies that address unmet patient needs. They are a cornerstone of clinical practice that enhance patient outcomes, particularly for those with complex or refractory cases who have exhausted standard treatment options. Clinicians understandably prioritize the well-being and interests of…

Confidently navigate the transition from bench to batch

FDA approves Merck’s Winrevair to treat pulmonary arterial hypertension

Report: Japan health authorities investigate Kobayashi Pharmaceutical factory after five deaths

Eicos Sciences’ FDA-approved Aurlumyn promises to drastically reduce frostbite amputations
Learn how to rapidly develop smart and sustainable engineering and production processes See More >

Personalized medicine: advanced technology is saving lives
The concept of a “batch size one” in pharmaceutical manufacturing is closer than ever. There are companies advancing cell therapies in which body cells are used to heal or support the individual patient. These cells are manipulated or edited to change certain biological characteristics before being transferred to the patient. Personalized medicine is truly about…
Facility See More >

MGS opens 300,000-square-foot Wisconsin facility to scale drug delivery device manufacturing
Healthcare CDMO manufacturer MGS has brought a 300,000 square foot drug delivery device manufacturing facility online in Richfield, Wisconsin. The move expands U.S. production capacity as demand for complex combination products strains available cleanroom capacity . FDA approved a record number of combination products in recent years, and the 505(b)(2) pathway has made device-drug combos…
Supply Chain See More >

Eli Lilly commits $4.5B to Indiana manufacturing sites, opens gene therapy plant
Eli Lilly (NYSE:LLY) announced today that it has committed an additional $4.5 billion investment across certain Indiana manufacturing sites. The company’s commitment extends to two of its three locations in Lebanon, Indiana. It brings its total Indiana capital expansion commitments since 2020 to more than $21 billion. This marks the latest investment across the U.S.,…
Recalls See More >

Report: Japan health authorities investigate Kobayashi Pharmaceutical factory after five deaths
Japanese health authorities searched a Kobayashi Pharmaceutical factory in Japan following reports of five deaths related to dietary supplements, Reuters reports. The plant inspection in western Japan is the second in recent days as health authorities inspected the company’s Osaka facility. In addition to the five reported deaths, there have been more than 100 hospitalizations…



































